Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,630 | 3,259 | 2,586 | 3,378 | 5,686 |
| Receivables | N/A | 1,195 | 1,143 | 714 | 928 |
| Other current assets | 0 | 1,090 | 2,539 | 4,866 | 2,998 |
| TOTAL | $1,732 | $6,070 | $6,785 | $9,638 | $10,662 |
| Non-Current Assets | |||||
| PPE Net | 594 | 2,822 | 4,667 | 3,678 | 3,101 |
| Intangibles | 2,044 | 696 | 667 | 1,004 | 966 |
| Other Non-Current Assets | 8,536 | 4,537 | 2,745 | 2,250 | 1,966 |
| TOTAL | $11,174 | $8,055 | $8,079 | $6,932 | $6,033 |
| Total Assets | $12,906 | $14,125 | $14,864 | $16,570 | $16,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 116 | 2,739 | 1,000 | 5,059 | 2,988 |
| Accounts payable and accrued liabilities | 1,275 | 835 | 271 | 390 | 247 |
| Accrued Expenses | 1,051 | 1,078 | 1,016 | 1,064 | 1,757 |
| Other current liabilities | 0 | 419 | 337 | 192 | 291 |
| TOTAL | $3,125 | $6,095 | $4,024 | $10,747 | $6,643 |
| Non-Current Liabilities | |||||
| Long Term Debt | 194 | 0 | 2,729 | 8 | 5,123 |
| Deferred Revenues | N/A | 460 | 1,267 | 3,746 | 1,059 |
| Other Non-Current Liabilities | 1,928 | 2,917 | 0 | 52 | 12 |
| TOTAL | $2,122 | $2,939 | $3,923 | $287 | $5,984 |
| Total Liabilities | $5,247 | $9,034 | $7,947 | $11,034 | $12,627 |
| Shareholders' Equity | |||||
| Common Shares | 25,800 | 14 | 14 | 13 | 11 |
| Retained earnings | -18,141 | -131,457 | -129,394 | -129,119 | -128,026 |
| Other shareholders' equity | 0 | -187 | -255 | -110 | -232 |
| TOTAL | $7,659 | $5,091 | $6,917 | $5,536 | $4,068 |
| Total Liabilities And Equity | $12,906 | $14,125 | $14,864 | $16,570 | $16,695 |